| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sr VP, Chief Financial Officer | Sr VP, Chief Fin & Ops Officer | Sr VP, CFO & COO +2 more
2 companies
Bernard Birkett last filed a Form 4 in February 2025, as Sr VP, Chief Financial Officer at WST. The filings on record cover 2 companies. Bernard Birkett's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 7,520 shares of WST. The WST filings lean toward selling, a net 36,508 shares.
Bernard Birkett has 24 Form 4 filings on record from November 2015 to February 2025, across 2 companies: Sr VP, Chief Financial Officer at West Pharmaceutical Services (WST), 2018–2025; Chief Financial Officer at Merit Medical Systems (MMSI), 2015–2018.
The 39 reported transactions were 13 option or other derivative awards, 8 stock awards, 7 open-market sales and 6 tax withholdings, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $13.2M.
The largest open-market sale was 22,334 shares of WST at an average $370.39 on August 2, 2023, about $8.3M. Twelve months later WST was down 18%.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | WST West Pharmaceutical Services Inc | Sr VP, Chief Fin & Ops Officer | Sale+OE | 22,334 | $370.39 | $8,272,215.84 | -83.6% | -14.1% | -18.3% | |
| Aug 2, 2022 | WST West Pharmaceutical Services Inc | Sr VP, CFO & COO | Sell | 14,174 | $341.19 | $4,836,074.26 | -94.7% | -32.1% | +9.6% | |
| Nov 30, 2015 | MMSI Merit Medical Systems Inc | Chief Financial Officer | Sale+OE | 3,750 | $19.31 | $72,412.50 | -77.7% | - | - |